Orion Infusion Limited (DSE:ORIONINFU)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
382.00
+12.00 (3.24%)
At close: Feb 26, 2026
0.66%
Market Cap 7.78B
Revenue (ttm) 665.43M
Net Income (ttm) 37.47M
Shares Out 20.36M
EPS (ttm) 1.84
PE Ratio 207.58
Forward PE n/a
Dividend 2.00 (0.52%)
Ex-Dividend Date Dec 2, 2025
Volume 826,168
Average Volume 346,914
Open 372.60
Previous Close 370.00
Day's Range 372.00 - 385.80
52-Week Range 303.30 - 587.50
Beta -2.36
RSI 59.37
Earnings Date Apr 29, 2026

About Orion Infusion

Orion Infusion Limited manufactures and sells large volume parenteral and other lifesaving injectable products in Bangladesh. The company offers I.V. rehydration, electrolyte, and acidosis solutions; ranitidine I.V. infusion; anti-microbial products; metronidazole I.V; pure steam generated fluids; and amino acids solution. It also provides sterile and nonpyrogenic solution, such as Dextrolac, Dianak, Hartman, Manisol, Plasmasol, and Proliv; hypertonic solution, including Dextrosal, Electrodex-10, Fructose – 10, Orlev, Ortac; Dextropac, an isoto... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1983
Employees 563
Stock Exchange Dhaka Stock Exchange
Ticker Symbol ORIONINFU
Full Company Profile

Financial Performance

In fiscal year 2025, Orion Infusion's revenue was 664.92 million, a decrease of -19.64% compared to the previous year's 827.42 million. Earnings were 35.02 million, a decrease of -17.27%.

Financial Statements

News

There is no news available yet.